The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine

dc.centroFacultad de Medicinaes_ES
dc.contributor.authorLabella, Marina
dc.contributor.authorCéspedes Lagos, José Antonio
dc.contributor.authorDoña, Inmaculada
dc.contributor.authorShamji, Mohamed H.
dc.contributor.authorAgache, Ioana
dc.contributor.authorMayorga Mayorga, Cristobalina
dc.contributor.authorTorres-Jaén, María Josefa
dc.date.accessioned2022-05-09T06:33:53Z
dc.date.available2022-05-09T06:33:53Z
dc.date.issued2021-10-24
dc.departamentoMedicina y Dermatología
dc.description.sponsorshipThe present study has been supported by the Institute of Health ‘Carlos III’ (ISCIII) of the Ministry of Economy and Competitiveness (grants co-funded by European Regional Development Fund (ERDF): PI18/00095, RETICS ARADYAL RD16/0006/0001; Andalusian Regional Ministry Health (PE-0172- 2018). ML is supported by the ‘Río Hortega’ program [CM20/00210] from the ISCIII. CM holds a ‘Nicolas Monardes’ research contract (RC- 0004- 2021) and ID holds an SAS Stabilization contract (ref B-0001- 2017) by Andalusian Regional Ministry Health. Funding for open access charge: Universidad de Málaga / CBUAes_ES
dc.identifier.citationLabella M, Céspedes JA, Doña I, et al. The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine. Allergy. 2021;00:1– 13. https://doi.org/10.1111/all.15148es_ES
dc.identifier.doi10.1111/all.15148
dc.identifier.urihttps://hdl.handle.net/10630/24066
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessRightsopen accesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCOVID-19es_ES
dc.subject.otherAllergic reactionses_ES
dc.subject.otherBasophil activation testes_ES
dc.subject.otherBNT162b2es_ES
dc.subject.otherVaccineses_ES
dc.titleThe value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccinees_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublicationabcd4607-b47d-4018-86ad-3b5f76cbee1e
relation.isAuthorOfPublication.latestForDiscoveryabcd4607-b47d-4018-86ad-3b5f76cbee1e

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Allergy - 2021 - Labella - The value of the basophil activation test in the evaluation of patients reporting allergic.pdf
Size:
1.16 MB
Format:
Adobe Portable Document Format
Description:

Collections